These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 3485375
1. Multimeric pattern discrepancy between platelet and plasma von Willebrand factor in type IIC von Willebrand disease. Batlle J, López Fernández MF, Fernández Villamor A, López Berges C, Zimmerman TS. Am J Hematol; 1986 May; 22(1):87-8. PubMed ID: 3485375 [Abstract] [Full Text] [Related]
2. A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure. Gralnick HR, Williams SB, McKeown LP, Maisonneuve P, Jenneau C, Sultan Y. Am J Hematol; 1987 Mar; 24(3):259-66. PubMed ID: 3493688 [Abstract] [Full Text] [Related]
3. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity. Federici AB, Mannucci PM, Lombardi R, Lattuada A, Colibretti ML, Dent JA, Zimmerman TS. Am J Hematol; 1989 Dec; 32(4):287-93. PubMed ID: 2510503 [Abstract] [Full Text] [Related]
4. In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Gralnick HR, Williams SB, McKeown LP, Maisonneuve P, Jenneau C, Sultan Y, Rick ME. Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5968-72. PubMed ID: 2994057 [Abstract] [Full Text] [Related]
5. Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the Factor VIII and von Willebrand Factor Subcommittee. Mannucci PM, Abildgaard CF, Gralnick HR, Hill FG, Hoyer LW, Lombardi R, Nilsson IM, Tuddenham E, Meyer D. Thromb Haemost; 1985 Dec 17; 54(4):873-6. PubMed ID: 3879020 [Abstract] [Full Text] [Related]
9. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level. Weiss DR, Strasser EF, Ringwald J, Zimmermann R, Eckstein R. Clin Lab; 2012 Dec 17; 58(11-12):1203-9. PubMed ID: 23289190 [Abstract] [Full Text] [Related]
13. Investigation of type IIC von Willebrand disease. Uno H, Nishida N, Ishizaki J, Suzuki M, Nishikubo T, Miyata S, Takahashi Y, Yoshioka A, Tsuda K. Int J Hematol; 1994 Apr 17; 59(3):219-25. PubMed ID: 8011991 [Abstract] [Full Text] [Related]
16. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays. Favaloro EJ. Blood Coagul Fibrinolysis; 2011 Oct 17; 22(7):553-64. PubMed ID: 21885953 [Abstract] [Full Text] [Related]
17. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Clin Appl Thromb Hemost; 2006 Oct 17; 12(4):397-420. PubMed ID: 17000885 [Abstract] [Full Text] [Related]
18. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Favaloro EJ. Semin Thromb Hemost; 2008 Feb 17; 34(1):113-27. PubMed ID: 18393148 [Abstract] [Full Text] [Related]